Quality Care
The company will maintain its patent right for the technology.
Docquity will use its fresh funds to further expand into East Asia and the Middle East.
Also, Lunit has received Taiwan's approval for its AI mammography solution.
The AI model still has a modest prediction accuracy and is slated for a wider clinical trial soon.
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.
This comes after it launched its CDI tool called DxPrime in June.
A review of studies published in npj Digital Medicine found diagnostic and triage accuracy varied but was generally low, raising concerns about using symptom checkers as patient-facing tools.
Dozee's sensor-based technology uses AI to track vital parameters.
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.
Also, Northwestern University spinout Sibel Health raises $33 million, and real-world evidence startup Atropos Health scoops up $14 million.